← Back to Search

Prehabilitation for Tricuspid Regurgitation

N/A
Waitlist Available
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-5 days (day 1 to day 4 of prehab or day of surgical intervention)
Awards & highlights
No Placebo-Only Group

Summary

This study will aim to standardize the prehabilitation protocol to optimize patients and document the clinical and echo variables that could improve clinical outcomes of tricuspid valve intervention.

Eligible Conditions
  • Tricuspid Valve Disease
  • Tricuspid Regurgitation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-5 days (day 1 to day 4 of prehab or day of surgical intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-5 days (day 1 to day 4 of prehab or day of surgical intervention) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Nutritional Status
Change in Severity of Tricuspid Regurgitation by Echocardiographic assessment
Change in volume status according to daily input/outputs
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: PrehabilitationExperimental Treatment1 Intervention
All study patients will receive preoperative optimization with a standardized prehabilitation protocol prior to any intervention.

Find a Location

Who is running the clinical trial?

Baylor Research InstituteLead Sponsor
206 Previous Clinical Trials
203,416 Total Patients Enrolled
~2 spots leftby Nov 2025